**Question:** Which of the following drugs does not cause hypoglycemia:

A. Insulin
B. Glucagon
C. Metformin
D. Sulfonylureas

**Core Concept:** Hypoglycemia is a condition characterized by low blood glucose levels, which can lead to symptoms such as dizziness, confusion, and seizures. Drugs can cause hypoglycemia through different mechanisms, including increasing glucose production, decreasing glucose uptake, or enhancing insulin secretion.

**Why the Correct Answer is Right:** Glucagon is a hormone produced by alpha cells in the pancreas that plays a crucial role in maintaining blood glucose levels by stimulating glycogenolysis and gluconeogenesis in the liver, thereby raising blood glucose levels. Since glucagon counteracts the effects of insulin, a drug that mimics glucagon would be less likely to cause hypoglycemia.

**Why Each Wrong Option is Incorrect:**

A. Insulin: Insulin is a hormone produced by beta cells in the pancreas that lowers blood glucose levels by promoting glucose uptake into cells, particularly in muscles and adipose tissue. Therefore, insulin-mimicking drugs are more likely to cause hypoglycemia.

B. Sulfonylureas: These are a class of antidiabetic drugs that stimulate insulin secretion from beta cells in the pancreas, leading to increased glucose uptake and lowering blood glucose levels. Consequently, sulfonylureas are more likely to cause hypoglycemia.

C. Metformin: Metformin is a biguanide drug that reduces blood glucose levels by decreasing hepatic glucose production and enhancing insulin sensitivity in peripheral tissues. Like sulfonylureas, metformin is more likely to cause hypoglycemia.

D. Glucose-lowering agents: Drugs that directly lower blood glucose levels, such as insulin and sulfonylureas, are more likely to cause hypoglycemia. In contrast, glucagon (such as in glucagon-like peptide-1 receptor agonists) is less likely to cause hypoglycemia due to its counteracting effects on insulin.

**Clinical Pearl:** Hypoglycemia is a potential adverse effect to be considered when prescribing glucose-lowering medications, especially for patients with predisposing factors such as advanced age, renal impairment, and certain medications. It is crucial to monitor blood glucose levels when prescribing these drugs, especially in the early stages of therapy, and adjust the dosage accordingly.